STUDY SEARCH RESULTS

1 study found for your search request:  3475-057

Study of Pembrolizumab (MK-3475) and Pembrolizumab with Other Investigational Agents in Participants...
Condition: Bladder cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: Both
Study ID: NCT02625961
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site